These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29198986)

  • 1. Australian Trends in Procedural Characteristics and Outcomes in Patients Undergoing Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
    Biswas S; Duffy SJ; Lefkovits J; Andrianopoulos N; Brennan A; Walton A; Chan W; Noaman S; Shaw JA; Dawson L; Ajani A; Clark DJ; Freeman M; Hiew C; Oqueli E; Reid CM; Stub D
    Am J Cardiol; 2018 Feb; 121(3):279-288. PubMed ID: 29198986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, predictors, and clinical outcomes of early stent thrombosis in acute myocardial infarction patients treated with primary percutaneous coronary angioplasty (insights from the University of Ottawa Heart Institute STEMI registry).
    Singh K; Rashid M; So DY; Glover CA; Froeschl M; Hibbert B; Chong AY; Dick A; Labinaz M; Le May M
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):842-848. PubMed ID: 28733995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is routine post-procedural anticoagulation warranted after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction? Insights from the HORIZONS-AMI trial.
    Madhavan MV; Généreux P; Kirtane AJ; Xu K; Witzenbichler B; Mehran R; Stone GW
    Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):650-658. PubMed ID: 26124455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Out-of-Hours Presentation on Clinical Outcomes in ST-Elevation Myocardial Infarction.
    Biswas S; Brennan A; Duffy SJ; Andrianopoulos N; Chan W; Walton A; Noaman S; Shaw JA; Ajani A; Clark DJ; Freeman M; Hiew C; Oqueli E; Lefkovits J; Reid CM; Stub D
    Heart Lung Circ; 2020 Jun; 29(6):814-823. PubMed ID: 31262617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y
    J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of randomized clinical trials comparing bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention and in patients with ST-segment elevation myocardial infarction.
    Nairooz R; Sardar P; Amin H; Swaminathan RV; Kim LK; Chatterjee S; Feldman DN
    Am J Cardiol; 2014 Jul; 114(2):250-9. PubMed ID: 24890986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction: results from the Bremen STEMI Registry.
    Backhaus T; Fach A; Schmucker J; Fiehn E; Garstka D; Stehmeier J; Hambrecht R; Wienbergen H
    Clin Res Cardiol; 2018 May; 107(5):371-379. PubMed ID: 29230546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in door-to-balloon time and outcomes following primary percutaneous coronary intervention for ST-elevation myocardial infarction: an Australian perspective.
    Brennan AL; Andrianopoulos N; Duffy SJ; Reid CM; Clark DJ; Loane P; New G; Black A; Yan BP; Brooks M; Roberts L; Carroll EA; Lefkovits J; Ajani AE;
    Intern Med J; 2014 May; 44(5):471-7. PubMed ID: 24606571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Saltzman AJ; Stone GW; Claessen BE; Narula A; Leon-Reyes S; Weisz G; Brodie B; Witzenbichler B; Guagliumi G; Kornowski R; Dudek D; Metzger DC; Lansky AJ; Nikolsky E; Dangas GD; Mehran R
    JACC Cardiovasc Interv; 2011 Sep; 4(9):1011-9. PubMed ID: 21939942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials.
    Stone GW; Mehran R; Goldstein P; Witzenbichler B; Van't Hof A; Guagliumi G; Hamm CW; Généreux P; Clemmensen P; Pocock SJ; Gersh BJ; Bernstein D; Deliargyris EN; Steg PG
    J Am Coll Cardiol; 2015 Jan; 65(1):27-38. PubMed ID: 25572507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort Registry.
    Godschalk TC; Byrne RA; Adriaenssens T; Malik N; Feldman LJ; Guagliumi G; Alfonso F; Neumann FJ; Trenk D; Joner M; Schulz C; Steg PG; Goodall AH; Wojdyla R; Dudek D; Wykrzykowska JJ; Hlinomaz O; Zaman AG; Curzen N; Dens J; Sinnaeve P; Desmet W; Gershlick AH; Kastrati A; Massberg S; Ten Berg JM;
    JACC Cardiovasc Interv; 2017 Dec; 10(24):2548-2556. PubMed ID: 29268884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative).
    Alexander D; Mann N; Ou FS; Peterson ED; Ohman EM; Gibler WB; Roe MT
    Am J Cardiol; 2008 Nov; 102(10):1335-40. PubMed ID: 18993151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction-a registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial).
    Erlinge D; Koul S; Eriksson P; Scherstén F; Omerovic E; Linder R; Östlund OP; Wallentin L; Fröbert O; James S
    Am Heart J; 2016 May; 175():36-46. PubMed ID: 27179722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics, treatment and in-hospital outcomes of patients with STEMI in a metropolitan area of a developing country: an initial report of the extended Jakarta Acute Coronary Syndrome registry.
    Dharma S; Andriantoro H; Purnawan I; Dakota I; Basalamah F; Hartono B; Rasmin R; Isnanijah H; Yamin M; Wijaya IP; Pratama V; Gunarto TB; Juwana YB; Suling FR; Witjaksono AM; Lasanudin HF; Iskandarsyah K; Priatna H; Tedjasukmana P; Wahyumandradi U; Kosasih A; Budhiarti IA; Pribadi W; Wirianta J; Lubiantoro U; Pramesti R; Widowati DR; Aminda SK; Basalamah MA; Rao SV
    BMJ Open; 2016 Aug; 6(8):e012193. PubMed ID: 27580835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of door-to-balloon time on long-term mortality in high- and low-risk patients with ST-elevation myocardial infarction.
    Yudi MB; Ramchand J; Farouque O; Andrianopoulos N; Chan W; Duffy SJ; Lefkovits J; Brennan A; Spencer R; Fernando D; Hiew C; Freeman M; Reid CM; Ajani AE; Clark DJ;
    Int J Cardiol; 2016 Dec; 224():72-78. PubMed ID: 27631718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in Care and Outcomes for Emergency Medical Service-Transported Patients With ST-Elevation Myocardial Infarction (STEMI) With and Without Prehospital Cardiac Arrest: A Mission: Lifeline STEMI Accelerator Study.
    Kragholm K; Lu D; Chiswell K; Al-Khalidi HR; Roettig ML; Roe M; Jollis J; Granger CB
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29021273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
    Dörler J; Edlinger M; Alber HF; Altenberger J; Benzer W; Grimm G; Huber K; Pachinger O; Schuchlenz H; Siostrzonek P; Zenker G; Weidinger F;
    Eur Heart J; 2011 Dec; 32(23):2954-61. PubMed ID: 21920970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Outcomes and Prognosis of Patients With Versus Without Newly Diagnosed Diabetes Mellitus After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (the HORIZONS-AMI Study).
    Ertelt K; Brener SJ; Mehran R; Ben-Yehuda O; McAndrew T; Stone GW
    Am J Cardiol; 2017 Jun; 119(12):1917-1923. PubMed ID: 28427734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ST-Elevation Acute Myocardial Infarction in Australia-Temporal Trends in Patient Management and Outcomes 1999-2016.
    Aliprandi-Costa B; Morgan L; Snell LC; D Souza M; Kritharides L; French J; Brieger D; Ranasinghe I
    Heart Lung Circ; 2019 Jul; 28(7):1000-1008. PubMed ID: 30006115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States.
    Secemsky EA; Kirtane A; Bangalore S; Jovin IS; Shah RM; Ferro EG; Wimmer NJ; Roe M; Dai D; Mauri L; Yeh RW
    JACC Cardiovasc Interv; 2016 Dec; 9(23):2376-2386. PubMed ID: 27838271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.